ALB and pneumocystosis: The use of four or more clinical manifestations (cough, dyspnea, fever, chest pain, and weight loss) and albumin ≤30 g/L as predictive factors could enable clinicians to recognize the risk of PCP earlier and avoid further deterioration in the patient's condition.